Bmp-2 encapsulated polysaccharide nanoparticle modified biphasic calcium phosphate scaffolds for bone tissue regeneration

Journal of Biomedical Materials Research - Part A

Volumn 103, Issue 4, 2015, Pages 1520-1532

  Wang, Zhenming ^a   Wang, Kefeng ^b   Lu, Xiong ^a   Li, Minqi ^c   Liu, Hongrui ^c   Xie, Chaoming ^a   Meng, Fanzhi ^d   Jiang, Ou ^d   Li, Chen ^a   Zhi, Wei ^a  

^a State Key Laboratory of New Ceramics and Fine Processing   (China)

^b SICHUAN UNIVERSITY   (China)

^c People's Republic of China   (China)

^d The Second People s Hospital of Neijiang   (China)

Author keywords

Biphasic calcium phosphate scaffolds; BMP 2; Bone tissue regeneration; Chitosan; Chondroitin sulfate; Nanoparticles

Indexed keywords

BIOMATERIALS; BONE; CALCIUM; CALCIUM PHOSPHATE; CELL ADHESION; CHITIN; CHITOSAN; NANOPARTICLES; POLYELECTROLYTES; TISSUE; TISSUE REGENERATION;

BIPHASIC CALCIUM PHOSPHATES; BMP-2; BONE MORPHOLOGY PROTEINS; BONE TISSUE REGENERATION; CHONDROITIN SULFATES; ECTOPIC BONE FORMATIONS; POLYDOPAMINE COATING; POLYELECTROLYTE COMPLEXATION;

SCAFFOLDS (BIOLOGY);

BIPHASIC CALCIUM PHOSPHATE SCAFFOLD; BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATE; CHITOSAN NANOPARTICLE; COLLAGEN TYPE 1; DRUG CARRIER; GROWTH FACTOR; MOLECULAR SCAFFOLD; POLYDOPAMINE; POLYELECTROLYTE; POLYSACCHARIDE; UNCLASSIFIED DRUG; BOVINE SERUM ALBUMIN; CHITOSAN; CHONDROITIN SULFATE; HYDROXYAPATITE; HYDROXYAPATITE-BETA TRICALCIUM PHOSPHATE; NANOPARTICLE; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MARROW CULTURE; BONE MARROW STROMA CELL; BONE MASS; BONE MINERALIZATION; BONE REGENERATION; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL EVALUATION; COMPLEX FORMATION; COMPRESSIVE STRENGTH; CONTROLLED STUDY; DEGRADATION; DRUG DELIVERY SYSTEM; HIGH TEMPERATURE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; NANOENCAPSULATION; NONHUMAN; OSSIFICATION; PARTICLE SIZE; POROSITY; PROTEIN SECRETION; RABBIT; RAT; SURFACE CHARGE; SURFACE PROPERTY; SUSTAINED DRUG RELEASE; ZETA POTENTIAL; ANIMAL; BOVINE; CHEMISTRY; DRUG EFFECTS; METABOLISM; SPRAGUE DAWLEY RAT; STAINING; STATIC ELECTRICITY; TISSUE SCAFFOLD; ULTRASTRUCTURE;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CATTLE; CELL ADHESION; CHITOSAN; CHONDROITIN SULFATES; COLLAGEN TYPE I; HYDROXYAPATITES; IMMUNOHISTOCHEMISTRY; NANOPARTICLES; OSTEOGENESIS; PARTICLE SIZE; POLYSACCHARIDES; RABBITS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SERUM ALBUMIN, BOVINE; STAINING AND LABELING; STATIC ELECTRICITY; TISSUE SCAFFOLDS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84923608488     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.35282     Document Type: Article

References (53)

1. Roohani-Esfahani S, Lu Z, Li J, Ellis-Behnke R, Kaplan D, Zreiqat H. Effect of self-assembled nanofibrous silk/polycaprolactone layer on the osteoconductivity and mechanical properties of biphasic calcium phosphate scaffolds. Acta Biomater 2012;8:302-312.
2. Song G, Habibovic P, Bao C, Hu J, van Blitterswijk CA, Yuan H, Chen W, Xu H. The homing of bone marrow MSCs to nonosseous sites for ectopic bone formation induced by osteoinductive calcium phosphate. Biomaterials 2013;34:2167-2176.
3. Abbah SA, Liu J, Goh JCH, Wong H-K. Enhanced control of in vivo bone formation with surface functionalized alginate microbeads incorporating heparin and human bone morphogenetic pro-tein-2. Tissue Eng Part A 2012;19:350-359.
4. Sun X, Kang Y, Bao J, Zhang Y, Yang Y, Zhou X. Modeling vascularized bone regeneration within a porous biodegradable CaP scaffold loaded with growth factors. Biomaterials 2013;34:4971-4981.
5. Polak SJ, Levengood SKL, Wheeler MB, Maki AJ, Clark SG, Johnson AJW. Analysis of the roles of microporosity and BMP-2 on multiple measures of bone regeneration and healing in calcium phosphate scaffolds. Acta Biomater 2011;7:1760-1771.
6. Bose S, Tarafder S. Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: A review. Acta Biomater 2012;8:1401-1421.
7. Overman JR, Farré-Guasch E, Helder MN, ten Bruggenkate CM, Schulten EA, Klein-Nulend J. Short (15 minutes) bone morphogenetic protein-2 treatment stimulates osteogenic differentiation of human adipose stem cells seeded on calcium phosphate scaffolds in vitro. Tissue Eng Part A 2012;19:571-581.
8. Kleinschmidt K, Ploeger F, Nickel J, Glockenmeier J, Kunz P, Richter W. Enhanced reconstruction of long bone architecture by a growth factor mutant combining positive features of GDF-5 and BMP-2. Biomaterials 2013;34:5926-5936.
9. Hunziker E, Enggist L, Küffer A, Buser D, Liu Y. Osseointegration: The slow delivery of BMP-2 enhances osteoinductivity. Bone 2012;51:98-106.
10. Bramono DS, Murali S, Rai B, Ling L, Poh WT, Lim ZX, Stein GS, Nurcombe VV, Andre J, Cool SM. Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2). Bone 2012;50:954-964.
11. Murali S, Rai B, Dombrowski C, Lee J, Lim Z, Bramono D, Ling L, Bell T, Hinkley S, Nathan S. Affinity-selected heparan sulfate for bone repair. Biomaterials 2013;34:5594-5605.
12. Sellers RS, Zhang R, Glasson SS, Kim HD, Peluso D, D'AUGUSTA DA, Beckwith KM, Elisabeth A. Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2)∗. J Bone Joint Surg 2000;82:151-160.
13. Zara JN, Siu RK, Zhang X, Shen J, Ngo R, Lee M, Li W, Chiang M, Chung J, Kwak J. High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. Tissue Eng Part A 2011;17:1389-1399.
14. Luvizuto ER, Tangl S, Zanoni G, Okamoto T, Sonoda CK, Gruber R, Okamoto R. The effect of BMP-2 on the osteoconductive properties of b-tricalcium phosphate in rat calvaria defects. Biomaterials 2011;32:3855-3861.
15. Yang XB, Whitaker MJ, Sebald W, Clarke N, Howdle SM, Shakesheff KM, Oreffo RO. Human osteoprogenitor bone formation using encapsulated bone morphogenetic protein 2 in porous polymer scaffolds. Tissue Eng. 2004;10:1037-1045.
16. Luca L, Rougemont A-L, Walpoth BH, Gurny R, Jordan O. The effects of carrier nature and pH on rhBMP-2-induced ectopic bone formation. J Control Release 2010;147:38-44.
17. Chung Y-I, Ahn K-M, Jeon S-H, Lee S-Y, Lee J-H, Tae G. Enhanced bone regeneration with BMP-2 loaded functional nanoparticle-hydrogel complex. J Control Release 2007;121:91-99.
18. Jeon O, Song SJ, Yang HS, Bhang S-H, Kang S-W, Sung M, Lee J-H, Kim B-S. Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. Biochem Biophys Res Commun 2008;369:774-780.
19. Crouzier T, Sailhan F, Becquart P, Guillot R, Logeart-Avramoglou D, Picart C. The performance of BMP-2 loaded TCP/HAP porous ceramics with a polyelectrolyte multilayer film coating. Biomaterials 2011;32:7543-7554.
20. Yilgor P, Tuzlakoglu K, Reis RL, Hasirci N, Hasirci V. Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering. Biomaterials 2009;30:3551-3559.
21. Niu X, Feng Q, Wang M, Guo X, Zheng Q. Porous nano-HA/collagen/ PLLA scaffold containing chitosan microspheres for controlled delivery of synthetic peptide derived from BMP-2. J Control Release. 2009;134:111-117.
22. Son JS, Appleford M, Ong JL, Wenke JC, Kim JM, Choi SH, Oh DS. Porous hydroxyapatite scaffold with three-dimensional localized drug delivery system using biodegradable microspheres. J Control Release 2011;153:133-140.
23. Moghimi SM, Hunter AC, Murray JC. Long-circulating and targetspecific nanoparticles: Theory to practice. Pharmacol Rev 2001;53:283-318.
24. Tan Q, Tang H, Hu J, Hu Y, Zhou X, Tao Y, Wu Z. Controlled release of chitosan/heparin nanoparticle-delivered VEGF enhances regeneration of decellularized tissue-engineered scaffolds. Int J Nanomed 2011;6:929.
25. Tang D-W, Yu S-H, Ho Y-C, Mi F-L, Kuo P-L, Sung H-W. Heparinized chitosan/poly(g-glutamic acid) nanoparticles for multifunctional delivery of fibroblast growth factor and heparin. Biomaterials 2010;31:9320-9332.
26. Kean T, Thanou M. Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Delivery Rev 2010;62:3-11.
27. Lee D-W, Yun Y-P, Park K, Kim SE. Gentamicin and bone morphogenic protein-2 (BMP-2)-delivering heparinized-titanium implant with enhanced antibacterial activity and osteointegration. Bone 2012;50:974-982.
28. Lim JJ, Hammoudi TM, Bratt-Leal AM, Hamilton SK, Kepple KL, Bloodworth NC, McDevitt TC, Temenoff JS. Development of nano- and microscale chondroitin sulfate particles for controlled growth factor delivery. Acta Biomater 2011;7:986-995.
29. Park JS, Yang HJ, Woo DG, Yang HN, Na K, Park K-H. Chondrogenic differentiation of mesenchymal stem cells embedded in a scaffold by long-term release of TGF-b3 complexed with chondroitin sulfate. J Biomed Mater Res A 2010;92A:806-816.
30. Hu X, Neoh KG, Zhang J, Kang E-T, Wang W. Immobilization strategy for optimizing VEGF's concurrent bioactivity towards endothelial cells and osteoblasts on implant surfaces. Biomaterials 2012;33:8082-8093.
31. Bae SE, Choi J, Joung YK, Park K, Han DK. Controlled release of bone morphogenetic protein (BMP)2 2 from nanocomplex incorporated on hydroxyapatite-formed titanium surface. J Control Release 2012;160:676-684.
32. Macdonald ML, Samuel RE, Shah NJ, Padera RF, Beben YM, Hammond PT. Tissue integration of growth factor-eluting layer-by-layer polyelectrolyte multilayer coated implants. Biomaterials 2011;32:1446-1453.
33. Shah NJ, Macdonald ML, Beben YM, Padera RF, Samuel RE, Hammond PT. Tunable dual growth factor delivery from polyelectrolyte multilayer films. Biomaterials 2011;32:6183-6193.
34. Wang K, Leng Y, Lu X, Ren F. Calcium phosphate bioceramics induce mineralization modulated by proteins. Mater Sci Eng C Mater Biol Appl 2013;33:3245-3255.
35. Li D, Lu X, Lin H, Ren F, Leng Y. Chitosan/bovine serum albumin co-micropatterns on functionalized titanium surfaces and their effects on osteoblasts. J Mater Sci Mater Med 2013;24:489-502.
36. Brouwer J, van Leeuwen-Herberts T, de Ruit MO-v. Determination of lysozyme in serum, urine, cerebrospinal fluid and feces by enzyme immunoassay. Clin Chim Acta 1984;142:21-30.
37. Hou Y, Hu J, Park H, Lee M. Chitosan-based nanoparticles as a sustained protein release carrier for tissue engineering applications. J Biomed Mater Res A 2012;100:939-947.
38. Han L, Lin H, Lu X, Zhi W, Wang Kf, Meng Fz, Jiang O. BMP2-encapsulated chitosan coatings on functionalized Ti surfaces and their performance in vitro and in vivo. Mater Sci Eng C Mater Biol Appl 2014;40:1-8.
39. Suzuki H, Amizuka N, Oda K, Li M, Yoshie H, Ohshima H, Noda M, Maeda T. Histological evidence of the altered distribution of osteocytes and bone matrix synthesis in klotho-deficient mice. Arch Histol Cytol 2005;68:371-381.
40. Zomer Volpato F, Almodóvar J, Erickson K, Popat KC, Migliaresi C, Kipper MJ. Preservation of FGF-2 bioactivity using heparinbased nanoparticles, and their delivery from electrospun chitosan fibers. Acta Biomater 2012;8:1551-1559.
41. Almodóvar J, Kipper MJ. Coating electrospun chitosan nanofibers with polyelectrolyte multilayers using the polysaccharides heparin and N, N, N-trimethyl chitosan. Macromol Biosci 2011;11:72-76.
42. Heary RF, Schlenk RP, Sacchieri TA, Barone D, Brotea C. Persistent iliac crest donor site pain: Independent outcome assessment. Neurosurgery 2002;50:510-517.
43. Li JJ, Gil ES, Hayden RS, Li C, Roohani-Esfahani S-I, Kaplan DL, Zreiqat H. Multiple silk coatings on biphasic calcium phosphate scaffolds: Effect on physical and mechanical properties, and in vitro osteogenic response of human mesenchymal stem cells. Biomacromolecules 2013;14:2179-2188.
44. Cancedda R, Giannoni P, Mastrogiacomo M. A tissue engineering approach to bone repair in large animal models and in clinical practice. Biomaterials 2007;28:4240-4250.
45. Lan Levengood SK, Polak SJ, Wheeler MB, Maki AJ, Clark SG, Jamison RD, Wagoner Johnson AJ. Multiscale osteointegration as a new paradigm for the design of calcium phosphate scaffolds for bone regeneration. Biomaterials 2010;31:3552-3563.
46. Smith I, Baumann M, Obadia L, Bouler J-M. Surface potential and osteoblast attraction to calcium phosphate compounds is affected by selected alkaline hydrolysis processing. J Mater Sci Mater Med 2004;15:841-846.
47. Bose S, Tarafder S. Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: A review. Acta Biomater 2012;8:1401-1421.
48. Lan Levengood SK, Polak SJ, Poellmann MJ, Hoelzle DJ, Maki AJ, Clark SG, Wheeler MB, Wagoner Johnson AJ. The effect of BMP-2 on micro- and macroscale osteointegration of biphasic calcium phosphate scaffolds with multiscale porosity. Acta Biomater 2010;6:3283-3291.
49. Sohier J, Daculsi G, Sourice S, De Groot K, Layrolle P. Porous beta tricalcium phosphate scaffolds used as a BMP-2 delivery system for bone tissue engineering. J Biomed Mater Res A 2010;92:1105-1114.
50. de Guzman RC, Saul JM, Ellenburg MD, Merrill MR, Coan HB, Smith TL, Van Dyke ME. Bone regeneration with BMP-2 delivered from keratose scaffolds. Biomaterials 2012;34:1644-1655.
51. Jun S-H, Lee E-J, Jang T-S, Kim H-E, Jang J-H, Koh Y-H. Bone morphogenic protein-2 (BMP-2) loaded hybrid coating on porous hydroxyapatite scaffolds for bone tissue engineering. J Mater Sci Mater Med 2013;24:773-782.
52. Jeon O, Song SJ, Kang S-W, Putnam AJ, Kim B-S. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(l-lactic-co-glycolic acid) scaffold. Biomaterials 2007;28:2763-2771.
53. Jia X, Ma Z-Y, Zhang G-X, Hu J-M, Liu Z-Y, Wang H-Y, Zhou F. Polydopamine film coated controlled-release multielement compound fertilizer based on mussel-inspired chemistry. J Agric Food Chem 2013;61:2919-2924.